262 related articles for article (PubMed ID: 11333336)
1. Successful treatment of dry eye in two patients with chronic graft-versus-host disease with systemic administration of FK506 and corticosteroids.
Ogawa Y; Okamoto S; Kuwana M; Mori T; Watanabe R; Nakajima T; Yamada M; Mashima Y; Tsubota K; Oguchi Y
Cornea; 2001 May; 20(4):430-4. PubMed ID: 11333336
[TBL] [Abstract][Full Text] [Related]
2. Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease.
Ogawa Y; Okamoto S; Mori T; Yamada M; Mashima Y; Watanabe R; Kuwana M; Tsubota K; Ikeda Y; Oguchi Y
Bone Marrow Transplant; 2003 Apr; 31(7):579-83. PubMed ID: 12692625
[TBL] [Abstract][Full Text] [Related]
3. A Single-Center Pilot Prospective Study of Topical Application of Platelet-Derived Eye Drops for Patients with Ocular Chronic Graft-versus-Host Disease.
Zallio F; Mazzucco L; Monaco F; Astori MR; Passera R; Drago G; Tamiazzo S; Rapetti M; Dolcino D; Guaschino R; Pini M; Ladetto M
Biol Blood Marrow Transplant; 2016 Sep; 22(9):1664-1670. PubMed ID: 27269196
[TBL] [Abstract][Full Text] [Related]
4. [Prophylaxis and treatment of chronic graft versus host disease].
Huang K; Li Y; Huang SL; Fang JP; Zhou DH; Chen C
Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):174-7. PubMed ID: 15833186
[TBL] [Abstract][Full Text] [Related]
5. Graft-versus-host disease prophylaxis with tacrolimus and mycophenolate mofetil in HLA-matched nonmyeloablative transplant recipients is associated with very low incidence of GVHD and nonrelapse mortality.
Sabry W; Le Blanc R; Labbé AC; Sauvageau G; Couban S; Kiss T; Busque L; Cohen S; Lachance S; Roy DC; Roy J
Biol Blood Marrow Transplant; 2009 Aug; 15(8):919-29. PubMed ID: 19589481
[TBL] [Abstract][Full Text] [Related]
6. [Chronic graft-versus-host-disease involving the oral mucosa: clinical presentation and treatment].
Elad S; Levitt M; M Y S
Refuat Hapeh Vehashinayim (1993); 2008 Nov; 25(4):19-27, 72. PubMed ID: 19263864
[TBL] [Abstract][Full Text] [Related]
7. Topical tranilast for treatment of the early stage of mild dry eye associated with chronic GVHD.
Ogawa Y; Dogru M; Uchino M; Tatematsu Y; Kamoi M; Yamamoto Y; Ogawa J; Ishida R; Kaido M; Hara S; Matsumoto Y; Kawakita T; Okamoto S; Tsubota K
Bone Marrow Transplant; 2010 Mar; 45(3):565-9. PubMed ID: 19633693
[TBL] [Abstract][Full Text] [Related]
8. Topical tacrolimus with custom trays in the treatment of severe oral chronic graft-versus-host disease refractory to a potent topical steroid therapy: a case report.
Brown RS; Edwards D; Walsh-Chocolaad T; Childs RW
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Apr; 115(4):e26-30. PubMed ID: 23102802
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic serum eye drops for the treatment of dry eye patients with chronic graft-versus-host disease.
Na KS; Kim MS
J Ocul Pharmacol Ther; 2012 Oct; 28(5):479-83. PubMed ID: 22731244
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for the development of ocular graft-versus-host disease (GVHD) dry eye syndrome in patients with chronic GVHD.
Wang JC; Teichman JC; Mustafa M; O'Donnell H; Broady R; Yeung SN
Br J Ophthalmol; 2015 Nov; 99(11):1514-8. PubMed ID: 25947556
[TBL] [Abstract][Full Text] [Related]
11. Toxic tacrolimus levels after application of topical tacrolimus and use of occlusive dressings in two bone marrow transplant recipients with cutaneous graft-versus-host disease.
Olson KA; West K; McCarthy PL
Pharmacotherapy; 2014 Jun; 34(6):e60-4. PubMed ID: 24700567
[TBL] [Abstract][Full Text] [Related]
12. Experience with the use of salazosulfapyridine for intractable diarrhea after hematopoietic stem cell transplantation.
Moriguchi N; Isokawa S; Ando A; Miyata H
Int J Hematol; 2004 Dec; 80(5):463-6. PubMed ID: 15646661
[TBL] [Abstract][Full Text] [Related]
13. Long-term rebamipide and diquafosol in two cases of immune-mediated dry eye.
Yamane M; Ogawa Y; Fukui M; Kamoi M; Saijo-Ban Y; Yaguchi S; Mukai S; Kawakita T; Simmura S; Tsubota K
Optom Vis Sci; 2015 Apr; 92(4 Suppl 1):S25-32. PubMed ID: 25785527
[TBL] [Abstract][Full Text] [Related]
14. [Mycophenolate mofetil in treatment of graft-versus-host disease after allogeneic hematopoietic cell transplantation: analysis of 44 cases].
Chen H; Liu KY; Liu DH; Xu LP; Han W; Chen YH; Huang XJ
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(30):2127-30. PubMed ID: 19080474
[TBL] [Abstract][Full Text] [Related]
15. Severe oral chronic graft-versus-host disease following allogeneic bone marrow transplantation: highly effective treatment with topical tacrolimus.
Eckardt A; Starke O; Stadler M; Reuter C; Hertenstein B
Oral Oncol; 2004 Sep; 40(8):811-4. PubMed ID: 15288836
[TBL] [Abstract][Full Text] [Related]
16. Amelioration of steroid-resistant chronic graft-versus-host-mediated liver disease via tacrolimus treatment.
Nagler A; Menachem Y; Ilan Y
J Hematother Stem Cell Res; 2001 Jun; 10(3):411-7. PubMed ID: 11454316
[TBL] [Abstract][Full Text] [Related]
17. Acquired ichthyosis associated with chronic graft-versus-host disease following allogeneic peripheral blood stem cell transplantation in a patient with chronic myelogenous leukemia.
Dilek I; Demirer T; Ustün C; Arat M; Koç H; Beksaç M; Erdi H; Anadolu R; Ozcan M; Ilhan O; Akan H
Bone Marrow Transplant; 1998 Jun; 21(11):1159-61. PubMed ID: 9645582
[TBL] [Abstract][Full Text] [Related]
18. [Transient nephrotic syndrome after allogeneic bone marrow transplantation for chronic myelogenous leukemia].
Ishizuka Y; Yokota A; Hara S; Nakaseko C; Matsuura Y; Nishimura M; Saitoh Y
Rinsho Ketsueki; 2001 Apr; 42(4):321-7. PubMed ID: 11400304
[TBL] [Abstract][Full Text] [Related]
19. Optimal dose of rabbit thymoglobulin in conditioning regimens for unmanipulated, haploidentical, hematopoietic stem cell transplantation: Long-term outcomes of a prospective randomized trial.
Chang YJ; Wang Y; Mo XD; Zhang XH; Xu LP; Yan CH; Chen H; Chen YH; Chen Y; Han W; Wang FR; Wang JZ; Liu KY; Huang XJ
Cancer; 2017 Aug; 123(15):2881-2892. PubMed ID: 28301690
[TBL] [Abstract][Full Text] [Related]
20. A high-dose pulse steroid regimen for controlling active chronic graft-versus-host disease.
Akpek G; Lee SM; Anders V; Vogelsang GB
Biol Blood Marrow Transplant; 2001; 7(9):495-502. PubMed ID: 11669216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
